Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/214988
Title: Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Author: Nadeu, Ferran
Royo, Romina
Massoni Badosa, Ramon
Playà-Albinyana, Heribert
Garcia-Torre, Beatriz
Duran Ferrer, Martí
Dawson, Kevin J.
Kulis, Marta
Díaz Navarro, Ander
Villamor i Casas, Neus
Melero, Juan L.
Chapaprieta, Vicente
Dueso Barroso, Ana
Delgado, Julio
Moia, Riccardo
Ruiz Gil, Sara
Marchese, Domenica
Giró, Ariadna
Verdaguer Dot, Núria
Clot, Guillem
Rozman, María
Frigola, Gerard
Rivas Delgado, Alfredo
Baumann, Tycho
Alcoceba, Miguel
González,Marco
Climent, Fina
Abrisqueta Costa, Pau
Castellví, Josep
Bosch, Francesc
Aymerich Gregorio, Marta
Enjuanes, Anna
Ruiz Gaspà, Silvia
López Guillermo, Armando
Jares Gerboles, Pedro
Beà Bobet, Sílvia M.
Capella Gutiérrez, Salvador Jesús, 1985-
Gelpí Buchaca, Josep Lluís
López Bigas, Núria
Torrents Arenales, David
Campbell, Peter J.
Gut, Ivo G.
Rossi, Davide
Gaidano, Gianluca
Puente, Xose S.
Garcia Roves, Pablo M.
Colomer Pujol, Dolors
Heyn, Holger
Maura, Francesco
Martín-Subero, José Ignacio
Campo Güerri, Elias
Keywords: Leucèmia limfocítica crònica
Limfomes
Genètica
Patologia
Chronic lymphocytic leukemia
Lymphomas
Genetics
Pathology
Issue Date: 11-Aug-2022
Publisher: Nature Publishing Group
Abstract: Richter transformation (RT) is a paradigmatic evolution of chronic lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma conferring a dismal prognosis. The mechanisms driving RT remain largely unknown. We characterized the whole genome, epigenome and transcriptome, combined with single-cell DNA/RNA-sequencing analyses and functional experiments, of 19 cases of CLL developing RT. Studying 54 longitudinal samples covering up to 19 years of disease course, we uncovered minute subclones carrying genomic, immunogenetic and transcriptomic features of RT cells already at CLL diagnosis, which were dormant for up to 19 years before transformation. We also identified new driver alterations, discovered a new mutational signature (SBS-RT), recognized an oxidative phosphorylation (OXPHOS)high-B cell receptor (BCR)low-signaling transcriptional axis in RT and showed that OXPHOS inhibition reduces the proliferation of RT cells. These findings demonstrate the early seeding of subclones driving advanced stages of cancer evolution and uncover potential therapeutic targets for RT.
Note: Reproducció del document publicat a: https://doi.org/10.1038/s41591-022-01927-8
It is part of: Nature Medicine, 2022, vol. 28, num.8, p. 1662-1671
URI: https://hdl.handle.net/2445/214988
Related resource: https://doi.org/10.1038/s41591-022-01927-8
ISSN: 1078-8956
Appears in Collections:Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
251496.pdf28.57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons